The Journal of Pain
Volume 12, Issue 2 , Pages 194-204 , February 2011

Does Chronic Pain Alter the Normal Interaction Between Cardiovascular and Pain Regulatory Systems? Pain Modulation in the Hypertensive-Monoarthritic Rat

  • Dora Pinho

      Affiliations

    • Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Universidade do Porto, Portugal
    • IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal
  • ,
  • Manuela Morato

      Affiliations

    • Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Universidade do Porto, Portugal
    • REQUIMTE/Dept. Farmacologia, Faculdade de Farmácia, Universidade do Porto, Portugal
  • ,
  • Marta R. Couto

      Affiliations

    • Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Universidade do Porto, Portugal
    • IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal
  • ,
  • José Marques-Lopes

      Affiliations

    • Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Universidade do Porto, Portugal
    • IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal
  • ,
  • Isaura Tavares

      Affiliations

    • Instituto de Histologia e Embriologia, Faculdade de Medicina, Universidade do Porto, Portugal
    • IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal
  • ,
  • António Albino-Teixeira

      Affiliations

    • Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Universidade do Porto, Portugal
    • IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Portugal
    • Corresponding Author InformationAddress reprint requests to António Albino-Teixeira, Instituto de Farmacologia e Terapêutica, Faculdade de Medicina, Universidade do Porto Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.

Received 1 March 2010 ,Revised 23 April 2010 ,Accepted 24 June 2010.

References 

  1. Albino-Teixeira A, Matias A, Polónia J, Azevedo I. Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J Hypertension. 1991;9(Suppl 6):S196–S197
  2. Bileviciute I, Stenfors C, Theodorsson E, Beckman M, Lundeberg T. Significant changes in neuropeptide concentrations in the brain of normotensive (WKY) and spontaneously hypertensive (SHR) rats following knee joint monoarthritis. Brain Res. 1995;704:71–78
  3. Bolterman RJ, Manriquez MC, Ruiz MCO, Juncos LA, Romero JC. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension. 2005;46:943–947
  4. Bragdon EE, Light KC, Costello NL, Sigurdsson A, Bunting S, Bhalang K, et al. Group differences in pain modulation: Pain-free women compared to pain-free men and to women with TMD. Pain. 2002;96:227–237
  5. Bruehl S, Burns JW, McCubbin JA. Altered cardiovascular/pain regulatory relationships in chronic pain. Int J Behav Med. 1998;5:63–75
  6. Bruehl S, Chung OY, Ward P, Johnson B, McCubbin JA. The relationship between resting blood pressure and acute pain sensitivity in healthy normotensives and chronic back pain sufferers: The effects of opioid blockade. Pain. 2002;100:191–201
  7. Bruehl S, Dengler-Crish CM, Smith CA, Walker LS. Hypoalgesia related to elevated resting blood pressure is absent in adolescents and young adults with a history of functional abdominal pain. Pain. 2010;149:57–63
  8. Butler SH, Godefroy F, Besson JM, Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. J Pain. 1992;48:73–81
  9. Butler SH, Weil-Fugazza J. The foot-bend procedure as test of nociception for chronic studies in a model of monoarthritis in the rat. Pharmacol Commun. 1994;4:327–334
  10. Cangiano JL, Rodriguez-Sargent C, Martinez-Maldonado M. Effects of antihypertensive treatment on systolic blood pressure and renin in experimental hypertension in rats. J Pharmacol Exp Ther. 1979;208:310–313
  11. Castro AR, Bowery N, Castro-Lopes J. Baclofen and midazolam alter c-fos induction by peripheral noxious or innocuous stimulation in the spinal cord of normal and monoarthritic rats. Neuropharmacology. 1999;38:1775–1788
  12. Castro AR, Pinto M, Lima D, Tavares I. Nociceptive spinal neurons expressing NK1 and GABAB receptors are located in lamina I. Brain Res. 2004;1003:77–85
  13. Castro AR, Pinto M, Lima D, Tavares I. Secondary hyperalgesia in the monoarthritic rat is mediated by GABAB and NK1 receptors of spinal dorsal horn neurons: A behavior and c-fos study. Neuroscience. 2006;141:2087–2095
  14. Castro-Lopes JM, Tavares I, Tolle TR, Coito A, Coimbra A. Increase in GABAergic cells and GABA levels in the spinal cord in unilateral inflammation of the hindlimb in the rat. Eur J Neurosci. 1992;4:296–301
  15. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63
  16. Chung OY, Bruehl S, Diedrich L, Diedrich A, Chont M, Robertson D. Baroreflex sensitivity associated hypoalgesia in healthy states is altered by chronic pain. Pain. 2008;138:87–97
  17. Chung OY, Bruehl S, Diedrich L, Diedrich A. The impact of blood pressure and baroreflex sensitivity on wind-up. Anesth Analg. 2008;107:1018–1025
  18. Diatchenko L, Anderson AD, Slade GD, Fillingim RB, Shabalina SA, Higgins TJ, et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet. 2006;141:449–462
  19. Duschek S, Dietel A, Schandry R, Reyes-del-Paso GA. Increased sensitivity to heat pain in chronic low blood pressure. Eur J Pain. 2009;13:28–34
  20. Falcón BL, Stewart JM, Bourassa E, Katovich MJ, Walter G, Speth RC, et al. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension. Physiol Genomics. 2004;19:255–261
  21. Ferreira AA, Kwasniewski FH, Delani TC, Torres MG, Silva MA, Caparroz-Assef SM, et al. Acute immune and non-immune inflammatory response in spontaneously hypertensive rats and normotensive rats. Role of endogenous nitric oxide. Inflammation. 2007;30:198–204
  22. Ferreira-Gomes J, Adães S, Castro-Lopes JM. Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: A clinically relevant study. J Pain. 2008;9:945–954
  23. Ghione S. Hypertension-associated hypalgesia. Evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences. Hypertension. 1996;28:494–504
  24. Gillies LK, Lu M, Wang H, Lee RM. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats. Hypertension. 1997;30:1471–1478
  25. Guasti L, Grimoldi P, Diolisi A, Petrozzino MR, Gaudio G, Grandi AM, et al. Treatment with enalapril modifies the pain perception pattern in hypertensive patients. Hypertension. 1998;31:1146–1150
  26. Guasti L, Zanotta D, Diolisi A, Garganico D, Simoni C, Gaudio G, et al. Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade. J Hypertens. 2002;20:485–491
  27. Hagen K, Stovner LJ, Vatten L, Holmen J, Zwart JA, Bovim G. Blood pressure and risk of headache: A prospective study of 22,685 adults in Norway. J Neurol Neurosurg Psychiatry. 2002;72:463–466
  28. Hagen K, Zwart JA, Holmen J, Svebak S, Bovim G, Stovner LJ. Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trondelag Health Study. Arch Intern Med. 2005;165:916–922
  29. Harrison-Bernard LM, El-Dahr SS, O'Leary DF, Navar LG. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II–induced hypertension. Hypertension. 1999;33:340–346
  30. Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev. 2009;60:214–225
  31. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension. 2003;41:42–49
  32. Lee S, Lee B, Shin H. Changes in adrenal angiotensin II receptors in renin-dependent hypertensive rats. Arch Pharm Res. 1995;18:169–172
  33. Levine JD, Dardick SJ, Roizen MF, Helms C, Basbaum AI. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci. 1986;6:3423–3429
  34. Lima D, Avelino A, Coimbra A. Differential activation of c-fos in spinal neurones by distinct classes of noxious stimuli. Neuroreport. 1993;4:747–750
  35. Lima D, Albino-Teixeira A, Tavares I. The caudal medullary ventrolateral reticular formation in nociceptive-cardiovascular integration. An experimental study in the rat. Exp Physiol. 2002;87:267–274
  36. Maixner W, Fillingim R, Kincaid S, Sigurdsson A, Harris MB. Relationship between pain sensitivity and resting arterial blood pressure in patients with painful temporomandibular disorders. Psychosom Med. 1997;59:503–511
  37. McGaraughty S, Jarvis MF. Purinergic control of neuropathic pain. Drug Dev Res. 2006;67:376–388
  38. Milligan ED, Mehmert KK, Hinde JL, Harvey LO, Martin D, Tracey KJ, et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 2000;861:105–116
  39. Morato M, Pinho D, Sousa T, Tavares I, Albino-Teixeira A. Inhibition of nociceptive responses of spinal cord neurones during hypertension involves the spinal GABAergic system and a pain modulatory center located at the caudal ventrolateral medulla. J Neurosci Res. 2006;83:647–655
  40. Morato M, Sousa T, Guimarães S, Moura D, Albino-Teixeira A. The role of angiotensin II in hypertension due to adenosine receptors blockade. Eur J Pharmacol. 2002;455:135–141
  41. Pinto M, Lima D, Tavares I. Neuronal activation at the spinal cord and medullary pain control centers after joint stimulation: A c-fos study in acute and chronic articular inflammation. Neuroscience. 2007;132:905–916
  42. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25:319–325
  43. Raghavendra V, Kulkarni SK. AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema. Methods Find Exp Clin Pharmacol. 2000;22:633–636
  44. Randich A, Robertson JD. Spinal nociceptive transmission in the spontaneously hypertensive and Wistar-Kyoto normotensive rat. Pain. 1994;58:169–183
  45. Sawynok J. Adenosine and ATP receptors. Handb Exp Pharmacol. 2007;177:309–328
  46. Sitsen JM, de Yong W. Hypoalgesia in genetically hypertensive rats (SHR) is absent in rats with experimental hypertension. Hypertension. 1983;5:185–190
  47. Sousa T, Morato M, Albino-Teixeira A. Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors. Eur J Pharmacol. 2002;441:99–104
  48. Stovner LJ, Hagen K. Hypertension-associated hypalgesia: A clue to the comorbidity of headache and other pain disorders. Acta Neurol Scand Suppl. 2009;189:46–50
  49. Suematsu M, Suzuki H, Delano FA, Schmid-Schönbein GW. The inflammatory aspect of the microcirculation in hypertension: Oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation. 2002;9:259–276
  50. Sun L, Gao YH, Tian DK, Zheng JP, Zhu CY, Ke Y, et al. Inflammation of different tissues in spontaneously hypertensive rats. Acta Physiol Sin. 2006;58:318–323
  51. Tavares I, Albino-Teixeira A, Lima D. Hypertension inhibits noxious-evoked c-fos expression in the rat spinal cord. Neuroreport. 1995;6:1664–1668
  52. Tavares I, Almeida A, Albino-Teixeira A, Lima D. Lesions of the caudal ventrolateral medulla block the hypertension-induced inhibition of noxious-evoked c-fos expression in the rat spinal cord. Eur J Pain. 1997;1:149–160
  53. Tavares I, Lima D, Coimbra A. Neurones in the superficial dorsal horn of the rat spinal cord projecting to the medullary ventrolateral reticular formation express c-fos after noxious stimulation of the skin. Brain Res. 1993;623:278–286
  54. Taylor BK, Peterson MA, Basbaum AI. Exaggerated cardiovascular and behavioral nociceptive responses to subcutaneous formalin in the spontaneously hypertensive rat. Neurosci Lett. 1995;201:9–12
  55. Taylor BK, Roderick RE, Basbaum AI. Brainstem noradrenergic control of nociception is abnormal in the spontaneously hypertensive rat. Neurosci Lett. 2000;291:139–142
  56. Taylor BK, Roderick RE, St. Lezin E, Basbaum AI. Hypoalgesia and hyperalgesia with inherited hypertension in the rat. Am J Physiol Regulatory Integrative Comp Physiol. 2001;280:R345–R354
  57. Torres MG, Kwasniewski FH, Scaliante LG, Ishii-Iwamoto EL, Caparroz-Assef SM, Cuman RK, et al. Arthritis induced by adjuvant in spontaneously hypertensive and normotensive rats: Endogenous glucocorticoid effects on inflammatory response. Inflammation. 2009;32:20–26
  58. Wiehe M, Fuchs SC, Moreira LB, Moraes RS, Fuchs FD. Migraine is more frequent in individuals with optimal and normal blood pressure: A population-based study. J Hypertens. 2002;20:1303–1306
  59. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, et al. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Hypertension. 1990;15:459–468
  60. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, et al. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther. 1990;252:726–732
  61. Xu XJ, Plesan A, Yu W, Hao JX, Wiesenfeld-Hallin Z. Possible impact of genetic differences on the development of neuropathic pain-like behaviors after unilateral sciatic nerve ischemic injury in rats. Pain. 2001;89:135–145
  62. Zamir N, Segal M. Hypertension-induced analgesia: Changes in pain sensitivity in experimental hypertensive rat. Brain Res. 1979;160:170–173
  63. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

 Supported by the project POCTI/NSE/45409/2002 of FCT.

PII: S1526-5900(10)00583-3

doi: 10.1016/j.jpain.2010.06.009

The Journal of Pain
Volume 12, Issue 2 , Pages 194-204 , February 2011